EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of an antivirulence compound that targets the Staphylococcus aureus SaeRS two-component system to inhibit toxic shock syndrome toxin-1 production

Karine Dufresne, Dennis A DiMaggio, Carla S Maduta, Shaun R Brinsmade, John K McCormick

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Karine Dufresne und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada. Hauptthemen laut MEDLINE: Superantigens, Enterotoxins, Staphylococcus aureus, Bacterial Toxins. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, CIHR, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Menstrual toxic shock syndrome (mTSS) is a rare but severe disorder associated with the use of menstrual products such as high-absorbency tampons and is caused by Staphylococcus aureus strains that produce the toxic shock syndrome toxin-1 (TSST-1) superantigen. Herein, we screened a library of 3920 small bioactive molecules for the ability to inhibit transcription of the TSST-1 gene without inhibiting the growth of S. aureus. The dominant positive regulator of TSST-1 is the SaeRS two-component system (TCS), and we identified phenazopyridine hydrochloride (PP-HCl) that repressed the production of TSST-1 by inhibiting the kinase function of SaeS. PP-HCl competed with ATP for binding of the kinase SaeS leading to decreased phosphorylation of SaeR and reduced expression of TSST-1 as well as several other secreted virulence factors known to be regulated by SaeRS. PP-HCl targets the virulence of S. aureus, and it also decreases the impact of TSST-1 on human lymphocytes without affecting the healthy vaginal microbiota. Our findings demonstrate the promising potential of PP-HCl as a therapeutic strategy against mTSS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SuperantigensEnterotoxinsStaphylococcus aureusBacterial ToxinsBacterial ProteinsHumansFemaleShock, SepticGene Expression Regulation, BacterialProtein KinasesTranscription FactorsStaphylococcal InfectionsVirulenceLymphocytesMenstrual Hygiene Products

Stichwörter der Autor:innen

Staphylococcus aureusTSST-1anti-virulentmTSSphenazopyridine hydrochloride

Substanzen

SuperantigensEnterotoxinsenterotoxin F, StaphylococcalBacterial ToxinsBacterial ProteinsSaeS protein, Staphylococcus aureusProtein KinasesTranscription Factors

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.
  • Department of Biology, Georgetown University, Washington, District of Columbia, USA.
  • Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada. Electronic address: john.mccormick@uwo.ca.

Förderung

  • NIAID NIH HHS
  • CIHR
  • National Institutes of Health
  • McMaster University
  • Canadian Institutes of Health Research

Zitieren

APA

Dufresne, K., DiMaggio, D. A., Maduta, C. S., Brinsmade, S. R., & McCormick, J. K. (2024). Discovery of an antivirulence compound that targets the Staphylococcus aureus SaeRS two-component system to inhibit toxic shock syndrome toxin-1 production. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107455

Vancouver

Dufresne K, DiMaggio DA, Maduta CS, Brinsmade SR, McCormick JK. Discovery of an antivirulence compound that targets the Staphylococcus aureus SaeRS two-component system to inhibit toxic shock syndrome toxin-1 production. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107455

BibTeX
@article{Dufresne2024,
  author = {Dufresne, Karine and DiMaggio, Dennis A and Maduta, Carla S and Brinsmade, Shaun R and McCormick, John K},
  title = {Discovery of an antivirulence compound that targets the Staphylococcus aureus SaeRS two-component system to inhibit toxic shock syndrome toxin-1 production},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107455}
}
Kostenlos starten →